5-chloro-1-(2,4-dichlorobenzyl)-6-oxo-1,6-dihydro-3-pyridinecarbaldehyde
![]() |
- $418 - $603
- Product name: 5-chloro-1-(2,4-dichlorobenzyl)-6-oxo-1,6-dihydro-3-pyridinecarbaldehyde
- CAS: 1048913-46-7
- MF: C13H8Cl3NO2
- MW: 316.57
- EINECS:
- MDL Number:MFCD11100228
- Synonyms:5-chloro-1-(2,4-dichlorobenzyl)-6-oxo-1,6-dihydro-3-pyridinecarbaldehyde;3-Pyridinecarboxaldehyde, 5-chloro-1-[(2,4-dichlorophenyl)methyl]-1,6-dihydro-6-oxo-
3 prices
Selected condition:
Brand
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- ManufacturerCrysdot
- Product numberCD11360024
- Product description5-Chloro-1-(2,4-dichlorobenzyl)-6-oxo-1,6-dihydropyridine-3-carbaldehyde 95+%
- Packaging1g
- Price$418
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number047355
- Product description5-Chloro-1-(2,4-dichlorobenzyl)-6-oxo-1,6-dihydro-3-pyridinecarbaldehyde >95%
- Packaging500mg
- Price$486
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number047355
- Product description5-Chloro-1-(2,4-dichlorobenzyl)-6-oxo-1,6-dihydro-3-pyridinecarbaldehyde >95%
- Packaging1g
- Price$603
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11360024 | 5-Chloro-1-(2,4-dichlorobenzyl)-6-oxo-1,6-dihydropyridine-3-carbaldehyde 95+% | 1g | $418 | 2021-12-16 | Buy |
Matrix Scientific | 047355 | 5-Chloro-1-(2,4-dichlorobenzyl)-6-oxo-1,6-dihydro-3-pyridinecarbaldehyde >95% | 500mg | $486 | 2021-12-16 | Buy |
Matrix Scientific | 047355 | 5-Chloro-1-(2,4-dichlorobenzyl)-6-oxo-1,6-dihydro-3-pyridinecarbaldehyde >95% | 1g | $603 | 2021-12-16 | Buy |
Properties
Melting point :130-132°
Boiling point :450.5±45.0 °C(Predicted)
Density :1.52±0.1 g/cm3(Predicted)
pka :-4.80±0.70(Predicted)
Boiling point :450.5±45.0 °C(Predicted)
Density :1.52±0.1 g/cm3(Predicted)
pka :-4.80±0.70(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|